KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Net Income (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Net Income for 17 consecutive years, with $720.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Net Income rose 200.59% to $720.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $759.9 million, a 141.2% increase, with the full-year FY2025 number at $759.9 million, up 141.2% from a year prior.
  • Net Income was $720.0 million for Q4 2025 at Bio-Rad Laboratories, up from -$341.9 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $3.9 billion in Q3 2021 to a low of -$3.4 billion in Q1 2022.
  • A 5-year average of -$54.9 million and a median of $87.6 million in 2023 define the central range for Net Income.
  • Peak YoY movement for Net Income: tumbled 444.51% in 2022, then surged 514.69% in 2024.
  • Bio-Rad Laboratories' Net Income stood at -$1.6 billion in 2021, then surged by 152.88% to $827.8 million in 2022, then tumbled by 57.75% to $349.7 million in 2023, then tumbled by 304.67% to -$715.8 million in 2024, then surged by 200.59% to $720.0 million in 2025.
  • Per Business Quant, the three most recent readings for BIO's Net Income are $720.0 million (Q4 2025), -$341.9 million (Q3 2025), and $317.8 million (Q2 2025).